Leveraging Epigenetic Biomarkers and CRISPR-Cas12a for Early Prostate Cancer Detection in Sub-Saharan Africa: Opportunities and Challenges
| dc.contributor.author | Nguedia, Niela K. | |
| dc.contributor.author | Amadi, Emmanuel C. | |
| dc.contributor.author | Kintung, Irrinus F. | |
| dc.contributor.author | Ogunlana, Olubanke O. | |
| dc.contributor.author | Chinedu, Shalom N. | |
| dc.date.accessioned | 2026-02-18T15:16:47Z | |
| dc.date.issued | 2025 | |
| dc.identifier.issn | doi: 10.20944/preprints202507.09B4.v1 | |
| dc.identifier.uri | https://repository.covenantuniversity.edu.ng/handle/123456789/50619 | |
| dc.language.iso | en | |
| dc.subject | epigenetic signatures | |
| dc.subject | CRISPR-Cas12a | |
| dc.subject | prostate cancer | |
| dc.subject | early detection | |
| dc.subject | liquid biopsy | |
| dc.subject | SubSaharan Africa | |
| dc.title | Leveraging Epigenetic Biomarkers and CRISPR-Cas12a for Early Prostate Cancer Detection in Sub-Saharan Africa: Opportunities and Challenges | |
| dc.type | Article |